Clinical trials: Breast Cancer, Liquid Biopsy, Early Detection

Hereditary Cancer Syndrome

CfDNA in Hereditary And High-risk Malignancies 2

• Recruiting
• Age: Up to 90 years
• Observational study

The goal of this study is to understand the performance of an experimental blood test that aims to detect early tumors in patients with hereditary cancer syndromes.

Trial name

CHARM2 (NCT06726642)

Testing

Cell-free DNA analysis

Where

8 sites in Canada

Volunteers

1,000 people

Sponsor

University Health Network, Toronto